Universal Linker "Maleimide-Type Linker Supports"

In solid-phase synthesis using the phosphoramidite method, nucleoside linkers--nucleosides fixed to a solid support via a linker--are used to attach the 3' terminal nucleoside of the oligonucleotide being synthesized. Since the 3' terminal nucleoside varies depending on the oligonucleotide sequence, this method requires preparing eight types of nucleoside linkers for DNA (dA, dG, dC, dT) and RNA (rA, rG, rC, rU), as well as additional modified nucleoside linkers when synthesizing modified oligonucleotides, which can be cumbersome. To solve this problem, solid supports modified with a universal linker have been developed as an alternative to conventional nucleoside linkers.

Currently, the most widely used universal linker is UnyLinker™*, developed by Ionis Pharmaceuticals, which is a linker bearing a maleimide ring. In recent years, universal linkers with new backbones, as well as conditions for cleaving the universal linker from the solid support, have also been developed.

This product is a solid support modified with a universal linker developed by Ionis Pharmaceuticals. It is offered under the product name "Maleimide-type Linker." A lineup of multiple pore sizes is available, so you can choose the optimal pore size according to the type of oligonucleotide to be synthesized.

*UnyLinker™ is a trademark of Ionis Pharmaceuticals, Inc.

Applications

Synthesis of oligonucleotides (T10 and T20) using Maleimide-Type Linker PS in DMTr-Off mode

1) Synthesis of T10mer

Solid Supports UnyLinker™ Crude Yield
(%)
Crude Purity
(HPLC, area%)
Supplier Materials Pore Size (Å) Substituent on N Functional Loading
(µmol/g)
T9
<N-1>
T10
<FLP>
1 FUJIFILM Wako HCP
(Low-Swelling Polymer)
1000 Ph 49 >90 5 92
2 2000 27 >90 3 92
3 3000 29 >90 4 90
4 4000 8 >90 4 90
C1 Competitor A CPG 500 Ph 90 69 10 83
C2 1000 48 71 7 87
C3 Competitor B CPG 1000 Me 45 67 2 93
C4 Competitor C Swelling Polymer Swelling Pore Ph 407 73 1 95
C5 Competitor D 347 79 2 94

Note: These results were obtained from limited sample sizes and specific conditions

a) FUJIFILM Wako PS 1000Å

a) FUJIFILM Wako PS 1000Å

b) Competitor CPG 1000Å

b) Competitor CPG 1000Å

Figure HPLC analysis of ONs released from T10-loaded (a) UnyLinker™ PS 1000Å (R=Ph) and (b) UnyLinker™ CPG 1000Å (R=Me) under Basic conditions. Basic condition: AMA at 60℃ for 1 h.

HPLC condition of Oligonucleotide
Column size : Wakopak® Ultra C18-2 φ2.1 mm×100 mm (D)
Mobile phase : A) 100 mM TEAA aq., B) Acetonitrile
Gradient : 0-15 min B=5-15%, 15-20 min B=100%, 20-25 min B=5%
Flow rate : 0.3 mL/min
Temperature : 40℃
Detection : UV260 nm
Injection vol. : 0.5 µL
Sample : DNA dT 10 mer, All PO

2) Synthesis of T20mer

Solid Supports UnyLinker™ Crude Yield
(%)
Crude Purity
(HPLC, area%)
Supplier Materials Pore Size (Å) Substituent on N Functional Loading
(µmol/g)
T19
<N-1>
T20
<FLP>
1 FUJIFILM Wako HCP
(Low-Swelling Polymer)
1000 Ph 29 >90 5 87
2 2000 19 >90 4 83
3 3000 20 >90 5 80
4 4000 8 >90 5 84
C1 Competitor A CPG 500 Ph 90 73 12 80
C2 1000 48 69 7 83
C3 Competitor B CPG 1000 Me 45 68 8 86
C4 Competitor C Swelling Polymer Swelling pore Ph 407 57 4 79
C5 Competitor D 347 69 12 78

Note: These results were obtained from limited sample sizes and specific conditions

HPLC condition of Oligonucleotide
Column size : Wakopak® Ultra C18-2 φ2.1 mm×100 mm (D)
Mobile phase : A) 100 mM HFIP + 8.6mM TEA aq., B) Acetonitrile
Gradient : 0-15 min B=1-9%, 15-20 min B=100%, 20-25 min B=1%
Flow rate : 0.3 mL/min
Temperature : 40℃
Detection : UV260 nm
Injection vol. : 0.25 µL
Sample : DNA dT 20 mer, All PO

Product List

  • Open All
  • Close All

Related Product List

  • Open All
  • Close All

For research use or further manufacturing use only. Not for use in diagnostic procedures.

Product content may differ from the actual image due to minor specification changes etc.

If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.